Oncotelic issues $0.25M convertible note to Fourth Man, LLC at 12% interest

Oncotelic Therapeutics, Inc.

Convertible promissory note principal $0.25M, 12% annual interest, matures in one year.
Conversion price fixed at $0.10 per share; also issued 1,250,000 warrants at $0.20 exercise.
Finder's fee to JH Darbie: 10% of gross proceeds plus warrants equal to 10% of amount raised.
Proceeds for general working capital and repayment of certain debt; same terms as November 2021 issuances.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.